# Longboard Pharmaceuticals Inc. (LBPH)

Source: https://www.quantisnow.com/company/LBPH
Generated: 2026-11-10T16:52:05.735Z

- Ticker: LBPH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: longboardpharma.com

## About

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.

## Latest LBPH news and filings

- 2026-03-18 06:30 UTC [Leadership Update] [Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report](https://www.quantisnow.com/insight/sensorion-reports-full-year-2025-results-provides-corporate-update-and-announces-6454330)
- 2025-04-02 05:30 UTC [Leadership Update] [Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director](https://www.quantisnow.com/insight/sensorion-strengthens-leadership-team-with-appointment-of-amit-munshi-as-5970829)
- 2024-12-12 13:10 UTC [SEC Form 15-12G filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-longboard-pharmaceuticals-inc-5810504)
- 2024-12-10 20:53 UTC [SEC Form POSASR filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-longboard-pharmaceuticals-inc-5807385)
- 2024-12-10 20:40 UTC [SEC Form RW WD filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-rw-wd-filed-by-longboard-pharmaceuticals-inc-5807364)
- 2024-12-10 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-longboard-pharmaceuticals-inc-5806481)
- 2024-12-10 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-longboard-pharmaceuticals-inc-5806479)
- 2024-12-10 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-longboard-pharmaceuticals-inc-5806468)
- 2024-12-03 00:29 UTC [SEC Form 4] [SEC Form 4 filed by Director Lynch Casey](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-lynch-casey-5796677)
- 2024-12-03 00:27 UTC [SEC Form 4] [SEC Form 4 filed by Director Le Goff Corinne](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-le-goff-corinne-5796667)
- 2024-12-03 00:26 UTC [SEC Form 4] [SEC Form 4 filed by Director Sekhri Paul J](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-sekhri-paul-j-5796663)
- 2024-12-03 00:24 UTC [SEC Form 4] [SEC Form 4 filed by Director Schneider Phillip M](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-schneider-phillip-m-5796661)
- 2024-12-03 00:22 UTC [SEC Form 4] [SEC Form 4 filed by Director Aurentz Vincent](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-aurentz-vincent-5796660)
- 2024-12-03 00:21 UTC [SEC Form 4] [Executive Vice President & CMO Kaye Randall closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/executive-vice-president-cmo-kaye-randall-closing-all-direct-ownership-5796656)
- 2024-12-03 00:19 UTC [SEC Form 4] [SEC Form 4 filed by Executive VP and CFO Roberts Brandi](https://www.quantisnow.com/insight/sec-form-4-filed-by-executive-vp-and-cfo-roberts-5796651)
- 2024-12-03 00:17 UTC [SEC Form 4] [President and CEO Lind Kevin Robert closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-lind-kevin-robert-closing-all-direct-ownership-5796649)
- 2024-12-02 16:30 UTC [SEC Form RW filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-longboard-pharmaceuticals-inc-5795615)
- 2024-12-02 14:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-longboard-pharmaceuticals-inc-5795479)
- 2024-12-02 14:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-longboard-pharmaceuticals-inc-5795478)
- 2024-12-02 14:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-longboard-pharmaceuticals-inc-5795477)
- 2024-12-02 14:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-longboard-pharmaceuticals-inc-5795475)
- 2024-12-02 14:07 UTC [SEC Form POS AM filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-longboard-pharmaceuticals-inc-5795471)
- 2024-12-02 14:07 UTC [SEC Form POS AM filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-longboard-pharmaceuticals-inc-5795470)
- 2024-12-02 14:07 UTC [SEC Form POS AM filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-longboard-pharmaceuticals-inc-5795469)
- 2024-12-02 14:05 UTC [SEC Form 8-K] [Longboard Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/longboard-pharmaceuticals-inc-filed-sec-form-8-k-termination-of-a-5795467)
- 2024-12-02 14:04 UTC [SEC Form 25-NSE filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-longboard-pharmaceuticals-inc-5795462)
- 2024-11-29 13:40 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-longboard-pharmaceuticals-inc-5794350)
- 2024-11-29 13:01 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-longboard-pharmaceuticals-inc-5794333)
- 2024-11-20 13:47 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-longboard-pharmaceuticals-inc-5784467)
- 2024-11-20 13:01 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-longboard-pharmaceuticals-inc-5784375)
- 2024-11-20 01:13 UTC [SEC Form 4] [CMO Kaye Randall exercised 30,554 shares at a strike of $6.00, increasing direct ownership by 171% to 48,474 units (SEC Form 4)](https://www.quantisnow.com/insight/cmo-kaye-randall-exercised-30554-shares-at-a-strike-of-5783927)
- 2024-11-15 11:18 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-longboard-pharmaceuticals-inc-5777991)
- 2024-11-14 20:10 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-longboard-pharmaceuticals-inc-5775063)
- 2024-11-14 18:22 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-longboard-pharmaceuticals-inc-5774581)
- 2024-11-14 01:48 UTC [SEC Form 4] [CEO Lind Kevin Robert exercised 12,808 shares at a strike of $3.12 and gifted 80,000 shares, decreasing direct ownership by 16% to 363,740 units (SEC Form 4)](https://www.quantisnow.com/insight/ceo-lind-kevin-robert-exercised-12808-shares-at-a-strike-5772689)
- 2024-11-12 20:59 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-longboard-pharmaceuticals-inc-5767049)
- 2024-11-12 13:30 UTC [Conference Announcement] [Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)](https://www.quantisnow.com/insight/longboard-pharmaceuticals-initiates-phase-3-deep-ocean-study-evaluating-bexicaserin-5764818)
- 2024-11-08 22:15 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-longboard-pharmaceuticals-inc-5763263)
- 2024-11-07 21:12 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Longboard Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-longboard-pharmaceuticals-inc-5759319)
- 2024-11-07 21:05 UTC [SEC Form 8-K] [Longboard Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/longboard-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-5759098)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LBPH
- Earnings history: https://www.quantisnow.com/earnings/LBPH
- Dividend history: https://www.quantisnow.com/dividends/LBPH
- Insider transactions: https://www.quantisnow.com/insiders/LBPH
- Options chain: https://www.quantisnow.com/options/LBPH
- SEC 8-K filings only: https://www.quantisnow.com/company/LBPH/8-k
- RSS and alerts for LBPH: https://www.quantisnow.com/docs/rss-feeds.md